Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12 Stomach Neoplasms 4 Colonic Neoplasms 2 To Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma 1 Rectal Neoplasms 1 Platinum Resistant Ovarian Cancer 1 Neoplasm Metastasis 1 HER2-positive Colorectal Cancer 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Colorectal Cancer Metastatic 1 Advanced Gastric Cancer 1

Interventions

Capecitabine 13 Oxaliplatin 10 Radiotherapy 8 Surgical Procedures, Operative 6 Drug Therapy 5 tislelizumab 4 Irinotecan 4 sintilimab 3 Neoadjuvant Therapy 3 Immunotherapy 3 Fluorouracil 3 Endoscopic Mucosal Resection 3 Bevacizumab 3 spartalizumab 2 raltitrexed 2 XELOX 2 Trinitrotoluene 2 Radiation 2 Immune Checkpoint Inhibitors 2 Folfox protocol 2 Cetuximab 2 toripalimab 1 sperm releasing substance 1 saxagliptin 1 s-formylglutathione hydrolase 1 envafolimab 1 disitamab vedotin 1 cemiplimab 1 camrelizumab 1 balstilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Rectal Neoplasms × HMPL-013 × Clear all

NCT06443671 2024-06-05

PKUCH-R09

Peking University Cancer Hospital & Institute

Phase 2/3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡